Director Shareholding

27th Jun 2005 17:11

United Drug PLC27 June 2005 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1. Name of company United Drug plc 2. Name of director Annette Flynn 3. Please state whether notification indicates that it is in respect of holdingof the shareholder named in 2 above or in respect of a non-beneficial interestor in the case of an individual holder if it is a holding of that person'sspouse or children under the age of 18 or in respect of a non-beneficialinterest As per 2 above 4. Name of the registered holder(s) and, if more than one holder, the number ofshares held by each of them (if notified) As per 2 above 5. Please state whether notification relates to a person(s) connected with thedirector named in 2 above and identify the connected person(s) n/a 6. Please state the nature of the transaction. For PEP transactions pleaseindicate whether general/single co PEP and if discretionary/non discretionary Granting of Options 7. Number of shares / amount of stock acquired N/a 8. Percentage of issued class n/a 9. Number of shares/amount of stock disposed n/a 10. Percentage of issued class n/a 11. Class of security €0.05 Ordinary Shares 12. Price per share n/a 13. Date of transaction n/a 14. Date company informed n/a 15. Total holding following this notification n/a 16. Total percentage holding of issued class following this notification n/a If a director has been granted options by the company please complete thefollowing boxes. 17. Date of grant 24 June 2005 18. Period during which or date on which exercisable 30,000 from 24 June 2008 to 23 June 2015 30,000 from 24 June 2010 to 23 June 2015 19. Total amount paid (if any) for grant of the option n/a 20. Description of shares or debentures involved: class, number 60,000 €0.05 Ordinary Shares 21. Exercise price (if fixed at time of grant) or indication that price is to befixed at time of exercise €3.48 22. Total number of shares or debentures over which options held following thisnotification 366,000 €0.05 ordinary shares 23. Any additional information 24. Name of contact and telephone number for queries Claire Heeley 25. Name and signature of authorised company official responsible for makingthis notification Date of Notification 27 June 2005 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1. Name of company United Drug plc 2. Name of director Barry McGrane 3. Please state whether notification indicates that it is in respect of holdingof the shareholder named in 2 above or in respect of a non-beneficial interestor in the case of an individual holder if it is a holding of that person'sspouse or children under the age of 18 or in respect of a non-beneficialinterest As per 2 above 4. Name of the registered holder(s) and, if more than one holder, the number ofshares held by each of them (if notified) As per 2 above 5. Please state whether notification relates to a person(s) connected with thedirector named in 2 above and identify the connected person(s) n/a 6. Please state the nature of the transaction. For PEP transactions pleaseindicate whether general/single co PEP and if discretionary/non discretionary Granting of Options 7. Number of shares / amount of stock acquired N/a 8. Percentage of issued class n/a 9. Number of shares/amount of stock disposed n/a 10. Percentage of issued class n/a 11. Class of security €0.05 Ordinary Shares 12. Price per share n/a 13. Date of transaction n/a 14. Date company informed n/a 15. Total holding following this notification n/a 16. Total percentage holding of issued class following this notification n/a If a director has been granted options by the company please complete thefollowing boxes. 17. Date of grant 24 June 2005 18. Period during which or date on which exercisable 75,000 from 24 June 2008 to 23 June 2015 25,000 from 24 June 2010 to 23 June 2015 19. Total amount paid (if any) for grant of the option n/a 20. Description of shares or debentures involved: class, number 100,000 €0.05 Ordinary Shares 21. Exercise price (if fixed at time of grant) or indication that price is to befixed at time of exercise €3.48 22. Total number of shares or debentures over which options held following thisnotification 633,500 €0.05 ordinary shares 23. Any additional information 24. Name of contact and telephone number for queries Claire Heeley 25. Name and signature of authorised company official responsible for makingthis notification Date of Notification 27 June 2005 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1. Name of company United Drug plc 2. Name of director Chris Corbin 3. Please state whether notification indicates that it is in respect of holdingof the shareholder named in 2 above or in respect of a non-beneficial interestor in the case of an individual holder if it is a holding of that person'sspouse or children under the age of 18 or in respect of a non-beneficialinterest As per 2 above 4. Name of the registered holder(s) and, if more than one holder, the number ofshares held by each of them (if notified) As per 2 above 5. Please state whether notification relates to a person(s) connected with thedirector named in 2 above and identify the connected person(s) n/a 6. Please state the nature of the transaction. For PEP transactions pleaseindicate whether general/single co PEP and if discretionary/non discretionary Granting of Options 7. Number of shares / amount of stock acquired N/a 8. Percentage of issued class n/a 9. Number of shares/amount of stock disposed n/a 10. Percentage of issued class n/a 11. Class of security €0.05 Ordinary Shares 12. Price per share n/a 13. Date of transaction n/a 14. Date company informed n/a 15. Total holding following this notification n/a 16. Total percentage holding of issued class following this notification n/a If a director has been granted options by the company please complete thefollowing boxes. 17. Date of grant 24 June 2005 18. Period during which or date on which exercisable 40,000 from 24 June 2008 to 23 June 2015 30,000 from 24 June 2010 to 23 June 2015 19. Total amount paid (if any) for grant of the option n/a 20. Description of shares or debentures involved: class, number 70,000 €0.05 Ordinary Shares 21. Exercise price (if fixed at time of grant) or indication that price is to befixed at time of exercise €3.48 22. Total number of shares or debentures over which options held following thisnotification 481,000 €0.05 ordinary shares 23. Any additional information 24. Name of contact and telephone number for queries Claire Heeley 25. Name and signature of authorised company official responsible for makingthis notification Date of Notification 27 June 2005 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1. Name of company United Drug plc 2. Name of director Claire Heeley 3. Please state whether notification indicates that it is in respect of holdingof the shareholder named in 2 above or in respect of a non-beneficial interestor in the case of an individual holder if it is a holding of that person'sspouse or children under the age of 18 or in respect of a non-beneficialinterest As per 2 above 4. Name of the registered holder(s) and, if more than one holder, the number ofshares held by each of them (if notified) As per 2 above 5. Please state whether notification relates to a person(s) connected with thedirector named in 2 above and identify the connected person(s) n/a 6. Please state the nature of the transaction. For PEP transactions pleaseindicate whether general/single co PEP and if discretionary/non discretionary Granting of Options 7. Number of shares / amount of stock acquired N/a 8. Percentage of issued class n/a 9. Number of shares/amount of stock disposed n/a 10. Percentage of issued class n/a 11. Class of security €0.05 Ordinary Shares 12. Price per share n/a 13. Date of transaction n/a 14. Date company informed n/a 15. Total holding following this notification n/a 16. Total percentage holding of issued class following this notification n/a If a director has been granted options by the company please complete thefollowing boxes. 17. Date of grant 24 June 2005 18. Period during which or date on which exercisable 10,000 from 24 June 2008 to 23 June 2015 40,000 from 24 June 2010 to 23 June 2015 19. Total amount paid (if any) for grant of the option n/a 20. Description of shares or debentures involved: class, number 50,000 €0.05 Ordinary Shares 21. Exercise price (if fixed at time of grant) or indication that price is to befixed at time of exercise €3.48 22. Total number of shares or debentures over which options held following thisnotification 85,000 €0.05 ordinary shares 23. Any additional information 24. Name of contact and telephone number for queries Claire Heeley 25. Name and signature of authorised company official responsible for makingthis notification Date of Notification 27 June 2005 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1. Name of company United Drug plc 2. Name of director Liam Fitzgerald 3. Please state whether notification indicates that it is in respect of holdingof the shareholder named in 2 above or in respect of a non-beneficial interestor in the case of an individual holder if it is a holding of that person'sspouse or children under the age of 18 or in respect of a non-beneficialinterest As per 2 above 4. Name of the registered holder(s) and, if more than one holder, the number ofshares held by each of them (if notified) As per 2 above 5. Please state whether notification relates to a person(s) connected with thedirector named in 2 above and identify the connected person(s) n/a 6. Please state the nature of the transaction. For PEP transactions pleaseindicate whether general/single co PEP and if discretionary/non discretionary Granting of Options 7. Number of shares / amount of stock acquired N/a 8. Percentage of issued class n/a 9. Number of shares/amount of stock disposed n/a 10. Percentage of issued class n/a 11. Class of security €0.05 Ordinary Shares 12. Price per share n/a 13. Date of transaction n/a 14. Date company informed n/a 15. Total holding following this notification n/a 16. Total percentage holding of issued class following this notification n/a If a director has been granted options by the company please complete thefollowing boxes. 17. Date of grant 24 June 2005 18. Period during which or date on which exercisable 75,000 from 24 June 2008 to 23 June 2015 25,000 from 24 June 2010 to 23 June 2015 19. Total amount paid (if any) for grant of the option n/a 20. Description of shares or debentures involved: class, number 100,000 €0.05 Ordinary Shares 21. Exercise price (if fixed at time of grant) or indication that price is to befixed at time of exercise €3.48 22. Total number of shares or debentures over which options held following thisnotification 1,403,000 €0.05 ordinary shares 23. Any additional information 24. Name of contact and telephone number for queries Claire Heeley 25. Name and signature of authorised company official responsible for makingthis notification Date of Notification 27 June 2005 This announcement has been issued through the Companies Announcement Service of The Irish Stock Exchange This information is provided by RNS The company news service from the London Stock Exchange

---

Related Shares:

UDG.L